ULTRAGENYX PHARMACEUTICAL INC. (RARE)
Clinical trial NCT03993821 updates: 1. status: UNKNOWN → COMPLETED 2. completion date: 2023-03-01 → 2026-03-03 3. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT03993821 updates: 1. status: UNKNOWN → COMPLETED 2. completion date: 2023-03-01 → 2026-03-03 3. enrollment type: ESTIMATED → ACTUAL
📈 **POSITIVE** • Low confidence analysis (53%) • Moderate positive clinical data • Good growth prospects **Sentiment:** Positive (55%) **Content type:** Clinical